Brief: Pacira Biosciences FY Adjusted EBITDA USD 224 Million Vs. IBES Estimate USD 222 Million
27/02/2025 21:05
Feb 27 (Reuters) - Pacira Biosciences FY adjusted net income USD 157.7 million vs. IBES estimate USD 155.7 million. FY net income USD -100 million
Recent news on Pacira BioSciences
See all newsUS STOCKS ON THE MOVE-Palantir, Haemonetics
U.S. STOCKS ON THE MOVE-Palantir, Haemonetics, Starbucks
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal
Brief: Viatris - Pacira To Pay Viatris $62 Million Termination Fee Under Specified Circumstances
Pacira BioSciences jumps on $1.65 billion Viatris buyout deal